NCT00659360 2018-06-29AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 2 Completed17 enrolled 9 charts
NCT00475956 2010-04-15Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursAstraZenecaPhase 1 Completed40 enrolled